Results 161 to 170 of about 6,390 (207)

Development and validation of optical coherence tomography (OCT) and OCT angiography prediction model for short-term vitreous haemorrhage secondary to polypoidal choroidal vasculopathy. [PDF]

Br J Ophthalmol
Cheng S, Zhao X, Zhao Q, Meng L, Chen Y.
europepmc   +1 more source

Real world treatment outcomes in polypoidal choroidal vasculopathy in a Caucasian population of British ethnicity. [PDF]

Eye (Lond)
De Salvo G, Thulasidharan S, Barbara R, Penwarden A, Aggarwal N, Frisina R.   +5 more
europepmc   +1 more source

Comparison of One-Year Outcome of Intravitreal Aflibercept with or without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy. [PDF]

Medicina (Kaunas)
Weng HY, Chen FT, Wang LU, Huang TL, Ho WT, Chang PY, Hsu YR, Chen YJ, Wang JK.   +8 more
europepmc   +1 more source

Faricimab Treatment of Polypoidal Choroidal Vasculopathy Resistant to Intravitreal Ranibizumab Injections and Ranibizumab Port Delivery (Susvimo). [PDF]

J Vitreoretin Dis
Bloom J, Madani R, Haidar AJ, Alasil T.
europepmc   +1 more source

Pneumatic displacement of submacular haemorrhage secondary to neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. [PDF]

Eye (Lond)
Sim SS, Cheong KX, Chan HH, Choo JQH, Tsai ASH, Lee SY, Yeo IYS, Cheung CMG, Teo KYC.   +8 more
europepmc   +1 more source

Exploring and identifying the imaging biomarkers for predicting anti-VEGF treatment response in polypoidal choroidal vasculopathy: a prospective multicenter study. [PDF]

Ann Med
Zhang W, Gu X, Li B, Liu S, Yang J, Wang Y, Cheng S, Lv L, Li Z, Lu L, Zhang J, Zeng Q, Xiao Z, Liu G, Xin C, Zhang T, Su Y, Chen M, Wang C, Cun Y, Zhao X, Chen Y.   +21 more
europepmc   +1 more source

Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the EVEREST II Study. [PDF]

Ophthalmol Ther
Teo KYC, Park KH, Ngah NF, Chen SJ, Ruamviboonsuk P, Mori R, Kondo N, Lee WK, Rajagopalan R, Obata R, Wong IYH, Chee C, Terasaki H, Sekiryu T, Chen SC, Yanagi Y, Honda S, Lai TYY, Cheung CMG.   +18 more
europepmc   +1 more source

Evaluating photodynamic therapy versus brolucizumab as a second-line treatment for polypoidal choroidal vasculopathy. [PDF]

Int J Retina Vitreous
Funatsu R, Terasaki H, Mihara N, Sonoda S, Shiihara H, Sakamoto T.   +5 more
europepmc   +1 more source

Spontaneous resolution of photodynamic therapy-induced acute exudative maculopathy in a patient suffering from polypoidal choroidal vasculopathy: A case report with 3-year follow-up.

Oman J Ophthalmol
Rouvas A, Georgalas I, Tzanidaki ME, Gouliopoulos N.   +3 more
europepmc   +1 more source